Flu vaccine via microneedle patches generate robust immunity, safe in first human clinical trial

Despite the potentially severe consequences of illness and even death, only about 40 percent of adults in the United States receive flu shots each year; however, researchers believe a new self-administered, painless vaccine skin patch containing microscopic needles could significantly increase the number of people who get vaccinated. A phase I clinical trial conducted by ["]

The post Flu vaccine via microneedle patches generate robust immunity, safe in first human clinical trial appeared first on Outbreak News Today.